Koeberl, D., Schulze, A., Sondheimer, N., Lipshutz, G. S., Geberhiwot, T., Li, L., … Grunewald, S. (2024). Publisher Correction: Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia. Nature, 630(8017), E13. https://doi.org/10.1038/s41586-024-07646-z

Koeberl, Dwight, Andreas Schulze, Neal Sondheimer, Gerald S. Lipshutz, Tarekegn Geberhiwot, Lerong Li, Rajnish Saini, et al. “Publisher Correction: Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia.” Nature 630, no. 8017 (June 2024): E13. https://doi.org/10.1038/s41586-024-07646-z.

Koeberl D, Schulze A, Sondheimer N, Lipshutz GS, Geberhiwot T, Li L, et al. Publisher Correction: Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia. Nature. 2024 Jun;630(8017):E13.

Koeberl, Dwight, et al. “Publisher Correction: Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia.” Nature, vol. 630, no. 8017, June 2024, p. E13. Pubmed, doi:10.1038/s41586-024-07646-z.

Koeberl D, Schulze A, Sondheimer N, Lipshutz GS, Geberhiwot T, Li L, Saini R, Luo J, Sikirica V, Jin L, Liang M, Leuchars M, Grunewald S. Publisher Correction: Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia. Nature. 2024 Jun;630(8017):E13.